VIRIDIAN THERAPEUTICS INC. - COMMON STOCK
18.51
06-February-25 15:45:00
15 minutes delayed
Stocks
-0.73
-3.79%
Today's range
18.27 - 19.44
ISIN
N/A
Source
NASDAQ
-
Viridian Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
11 Aug 2021 06:00:01 By Nasdaq GlobeNewswire
-
Viridian Therapeutics to Participate in the Wedbush PacGrow Healthcare Virtual Conference
05 Aug 2021 07:30:00 By Nasdaq GlobeNewswire
-
Viridian Therapeutics Appoints Kristian Humer as Chief Financial Officer and Chief Business Officer
26 Jul 2021 06:30:00 By Nasdaq GlobeNewswire
-
15 Jul 2021 15:05:00 By Nasdaq GlobeNewswire
-
Viridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
14 Jul 2021 07:00:01 By Nasdaq GlobeNewswire
-
Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference
07 Jul 2021 07:00:01 By Nasdaq GlobeNewswire
-
Viridian Therapeutics to Participate in the JMP Securities Life Sciences Conference
10 Jun 2021 07:00:01 By Nasdaq GlobeNewswire
-
Viridian Therapeutics to Participate in Upcoming Investor Conferences
14 May 2021 07:00:00 By Nasdaq GlobeNewswire
-
Viridian Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Updates
06 May 2021 15:05:01 By Nasdaq GlobeNewswire
-
Viridian Therapeutics Reports 2020 Financial Results and Provides Corporate Updates
25 Mar 2021 15:05:00 By Nasdaq GlobeNewswire
-
09 Mar 2021 15:30:00 By Nasdaq GlobeNewswire